Literature DB >> 15578412

Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood.

Arthur C Ouwehand1, Maija Saxelin, Seppo Salminen.   

Abstract

The isolation of clinical isolates that are indistinguishable, by molecular methods, from the probiotic strain of Lactobacillus rhamnosus GG has been reported. We compared the virulence potential of these clinical isolates with that of the probiotic strain. It was observed that all isolates differed significantly in 1 or more phenotypic properties.

Entities:  

Mesh：

Year:  2004        PMID： 15578412     DOI： 10.1086/425741

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  11 in total

1.  Antimicrobial susceptibility of human blood culture isolates of Lactobacillus spp.

Authors:  M Danielsen; A Wind; J J Leisner; M Arpi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-04       Impact factor: 3.267

2.  Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia.

Authors:  Alla Aroutcheva; Julie Auclair; Martin Frappier; Mathieu Millette; Karen Lolans; Danielle de Montigny; Serge Carrière; Stephen Sokalski; William E Trick; Robert A Weinstein
Journal:  Probiotics Antimicrob Proteins       Date:  2016-03       Impact factor: 4.609

Review 3.  Risk and safety of probiotics.

Authors:  Shira Doron; David R Snydman
Journal:  Clin Infect Dis       Date:  2015-05-15       Impact factor: 9.079

4.  Intraspecific genotypic characterization of Lactobacillus rhamnosus strains intended for probiotic use and isolates of human origin.

Authors:  M Vancanneyt; G Huys; K Lefebvre; V Vankerckhoven; H Goossens; J Swings
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

Review 5.  Targeting gut microbiota as a possible therapy for mastitis.

Authors:  Xiaoyu Hu; Shumin Li; Yunhe Fu; Naisheng Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-05-11       Impact factor: 3.267

6.  Lactobacillus rhamnosus bacteremia: an emerging clinical entity.

Authors:  F Gouriet; M Million; M Henri; P-E Fournier; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-28       Impact factor: 3.267

Review 7.  Towards a better understanding of Lactobacillus rhamnosus GG--host interactions.

Authors:  Marijke E Segers; Sarah Lebeer
Journal:  Microb Cell Fact       Date:  2014-08-29       Impact factor: 5.328

8.  In silico analysis of protein toxin and bacteriocins from Lactobacillus paracasei SD1 genome and available online databases.

Authors:  Komwit Surachat; Unitsa Sangket; Panchalika Deachamag; Wilaiwan Chotigeat
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

Review 9.  Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer.

Authors:  Giuseppe L Banna; Francesco Torino; Francesco Marletta; Maria Santagati; Rossella Salemi; Elisa Cannarozzo; Luca Falzone; Francesco Ferraù; Massimo Libra
Journal:  Front Pharmacol       Date:  2017-09-01       Impact factor: 5.810

10.  Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement system.

Authors:  Eija Nissilä; François P Douillard; Jarmo Ritari; Lars Paulin; Hanna M Järvinen; Pia Rasinkangas; Karita Haapasalo; Seppo Meri; Hanna Jarva; Willem M de Vos
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.